AFP and hepatocellular carcinoma: One good example is the use of an algorithm incorporating biomarkers such as AFP, AST, ALT, and platelet counts and clinical features such as age and DM to achieve a risk-score-guided invitation, which resulted in a reduction of HCC mortality by more than 30% [25].